From: At-Risk Phenotype of Neurofibromatose-1 Patients: A Multicentre Case-Control Study
No SC-NFs (n = 102) Controls | 2-9 SC-NFs (n = 85) OR** (95%CI) | ≥10 SC-NFs (n = 21) OR** (95%CI) | |
---|---|---|---|
Paraspinal neurofibromas | 1 | 2.7 (1.4 - 5.3) | 82 (10.4 - 647.9) |
Distribution | |||
None | - | 1 | 1 |
Focal | 1 | 2.4 (1.2 - 5.0) | 10.3 (0.9 - 120.0) |
Diffuse | 1 | 5.4 (1.4 - 20.4) | 492.0 (48.4 - 5006.2) |
Location | |||
None | - | 1 | 1 |
Intradural | 1 | 3.7 (0.9 - 15.0) | 1270.0 (25.6 - 2849.8) |
Extradural | 1 | 2.4 (1.2 - 4.8) | 45.0 (5.4 - 374.2) |
Size | |||
None | - | 1 | 1 |
< 3 cm | 1 | 2.3 (1.1 - 4.9) | 58.6 (6.9 - 494.0) |
≥3 cm | 1 | 3.8 (1.4 - 10.4) | 136.7 (14.9 - 1253.9) |
Sciatic neurofibromas | 1 | 4.3 (2.1 - 9.0) | 29.1 (8.5 - 100.0) |
Distribution | |||
None | - | 1 | 1 |
Focal | 1 | 2.9 (1.2 - 7.0) | - |
Diffuse | 1 | 5.7 (1.5 - 21.7) | 266.8 (41.6 - 1712.7) |
Size | |||
None | - | 1 | 1 |
< 3 cm | 1 | 4.2 (1.8 - 9.8) | 27.2 (7.2 - 103.2) |
≥3 cm | 1 | 4.7 (1.4 - 15.5) | 33.4 (6.6 - 167.6) |
Neuropathies with SCV*** | 1 | 4.4 (0.9 - 22) | 29.9 (5.5 - 162.3) |